경구혈당강하제에 이차성 실패를 보이는 제2형 당뇨병환자에서의 GAD항체 및 췌장소도 세포질항체(ICA) = Antibodies to GAD and ICA in Type 2 DM with Secondary Failure of Oral Hypoglycemic Therapy

참고문헌 (Reference)

1 "소아 제1형 당뇨병환자에서 췌장 소도 세포질 항체와 Glutamic Acid Decarboxylase 항체" 22 : 145-154, 1998

2 "in the treatment of diabetes mellitus with tolbutamide and with phenformin. Diabetes 11" 88-93, 1962

3 "and -DR associations in type 1 diabetes mellitus with onset after age forty. Diabetes 31" 122-5, 1982

4 "What is the benefit of increasing the sulfonylurea dose? Ann Intern Med 118" 169-72, 1993

5 "UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group" 15 : 297-303, 1998

6 "UKPDS 25 : autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes" 350 : 1288-1293, 1997

7 "U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease" 44 : 1249-1258, 1995

8 "The value of islet cell antibody in predicting secondary failure of oral hypoglycemic agent therapy in diabetes mellitus. J Clin Lab Immunol 2" 23-6, 1979

9 "The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes" 27 : 1394-1398, 2004

10 "Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction" 112 (112): 1831-1842, 2003

11 "Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release. Diabetes Metab 15" 79-84, 1989

12 "Secondary failure of response to tolbutamide treatment. JAMA 171" 1786-92, 1959

13 "Secondary failure of oral hypoglycemic agents" 31-43, 1994

14 "Relationship between β-cell function and HLA antigens in patients with type 2" (n-insulin-dependent) : 29 757-60, 1986

15 "Predicting the need for insulin therapy in late onset" 40 1 105-7, 1984

16 "Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type 2 diabetes. Diabetes 37" 99-103, 1988

17 "Latent autoimmune diabetes mellitus in adults the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11" 299-303, 1994

18 "Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus" 33 : 89-97, 1996

19 "Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity" 38 : 816-822, 1995

20 "Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 25" 392-5, 1983

21 "Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes" 27 : 133-140, 1995

22 "Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets" 110 : 851-860, 2002

23 "Glucose and insulin responses to oral glucose in over non-insulin-dependent diabetic subjects with and without the islet cell antibody. Diabetes 29" 312-6, 1980

24 "Five-year follow-up of islet cell antibodies in type 2" (n-insulin dependent) : 34 402-8, 1991

25 "Desensitization of insulin secretion" 63 : 1921-1935, 2002

26 "Correlation of islet cell antibodies and HLA-DR phenotype with diabetes mellitus in adults. Diabetologia 27" 90-2, 1984

27 "Combination of two sulfonylureas. Does it make sense? Diabetes Care 11" 751-3, 1988

28 "Clinical studies on glibenclamide. Horm Metab Res 1" 5-60, 1969

29 "Clinical and pathogenic significance of pancreatic- islet-cell antibodies in diabetics treated with oral hypoglycemic agents. Lancet 1" 1025-7, 1977

30 "Cellular and humoral autoimmunity markers in type 2 diabetic patients with secondary drug failure. Diabetologia 35" (n-insulin-dependent) : 1159-64, 1992

31 "Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42" 359-62, 1993

32 "Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343" 1383-5, 1994

33 "Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy" 14 : 148-152, 1997

34 "A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323" 1167-72, 1990